Lexaria Bioscience Corp. LEXX 40.85
Health Care · NASDAQ · Data as of 2026-07-13
Lexaria Bioscience Corp. (LEXX) has delivered +25.4% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1393 of 1983 stocks overall and #173 of 263 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
40.85
Overall Rank
#1393 / 1983
Sector Rank
#173 / 263
Revenue CAGR
+25.4%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio